KABUTO owner Contact Information online
from Ishihara Sangyo Kaisha, Ltd.
KABUTO
US serial number:85124729
Application filling date:Sep. 08, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Apr. 21, 2014
Publication date:Jan. 18, 2011
Abandoned date:Apr. 21, 2014
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: fungicides
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 1(b)
Services:fungicides
Current owner owner name:Ishihara Sangyo Kaisha, Ltd.
Current owner owner address:3-15, Edobori, 1-Chome, Nishi-Ku,
Osaka-Shi, Osaka
JAPAN
Current owner legal entity type:CORPORATION
Current owner state or country:JAPAN
Attorney name:Susan Upton Douglass
Attorney email:sdouglass@fzlz.com
Attorney docket number:ISSK 1006133
Attorney email authorized:Yes
Correspondent name address:SUSAN UPTON DOUGLASS
FROSS ZELNICK LEHRMAN & ZISSU, P.C.
866 UNITED NATIONS PLZ
NEW YORK,
NEW YORK
UNITED STATES
10017-1822
Correspondent phone:212-813-5900
Correspondent email:sdouglass@fzlz.com
Correspondent fax:212-813-5901
Correspondent email authorized:Yes
Domestic representative name:Susan Upton Douglass
Domestic representative phone:212-813-5900
Domestic representative fax:212-813-5901
Domestic representative email:sdouglass@fzlz.com
Domestic representative email authorized:Yes
Trademark staff tm attorney:SALEMI, DOMINICK J
Trademark staff law office assigned KABUTO:LAW OFFICE 106
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (130) JOHNSON & JOHNSON (125) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) MERCK SHARP & DOHME CORP. (28) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Jan. 18, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010Similar brands
